Comparison between Avience Biomedicals IPO and Medistep Healthcare IPO.
Avience Biomedicals IPO is a SME Fixed Price IPO proposed to list at NSE SME while Medistep Healthcare IPO is a SME Fixed Price proposed to list at NSE SME.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Novus Capital Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Nirman Share Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹28.53 Cr whereas the issue size of the Medistep Healthcare IPO is up to ₹15.29 Cr. The final issue price of Avience Biomedicals IPO is ₹208.00 per share and of Medistep Healthcare IPO is ₹43.00 per share.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹196.00 per share | |
| Issue Price (Upper) | ₹208.00 per share | |
| Issue Price (Final) | ₹208.00 per share | ₹43.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 3000 shares |
| Fresh Issue Size | 13,71,600 shares | 35,55,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.53 Cr | up to ₹15.29 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,71,600 shares | 35,55,000 shares |
| Issue Size Total (Amount) | up to ₹28.53 Cr | up to ₹15.29 Cr |
Avience Biomedicals IPO opens on Jun 18, 2026, while Medistep Healthcare IPO opens on Aug 08, 2025. The closing date of Avience Biomedicals IPO and Medistep Healthcare IPO is Jun 22, 2026, and Aug 12, 2025, respectively.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2026 | |
| Issue Open | Jun 18, 2026 | Aug 08, 2025 |
| Issue Close | Jun 22, 2026 | Aug 12, 2025 |
| Basis Of Allotment (Tentative) | Jun 23, 2026 | Aug 13, 2025 |
| Initiation of Refunds (Tentative) | Jun 24, 2026 | Aug 14, 2025 |
| Credit of Share (Tentative) | Jun 24, 2026 | Aug 14, 2025 |
| Listing date (Tentative) | Jun 25, 2026 | Aug 18, 2025 |
| Anchor Lockin End date 1 | Jul 23, 2026 | |
| Anchor Lockin End date 2 | Sep 21, 2026 |
Avience Biomedicals IPO P/E ratio is 11.59, as compared to Medistep Healthcare IPO P/E ratio of 10.86.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.89% | 93.62% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.59% | 68.96% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.59 | 10.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹114.09 Cr. | ₹61.10 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 29.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | 38.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹17.94 | ₹3.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 49.89 | 29.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 4,81,200 shares while in Medistep Healthcare IPO retail investors are offered 4,81,200 shares. Qualified Institutional Buyers (QIB) are offered 2,73,600 shares in Avience Biomedicals IPO and 0 shares in Medistep Healthcare IPO.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,09,800 shares | |
| Market Maker Reservation | 82,200 shares | 1,89,000 shares |
| QIB | 2,73,600 shares | 0 shares |
| NII | 2,07,000 shares | 17,76,000 shares |
| RII | 4,81,200 shares | 17,79,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 13,71,600 shares | 35,55,000 shares |
Avience Biomedicals IPO subscribed 270.19x in total, whereas Medistep Healthcare IPO subscribed 375.20x.
| Avience Biomedicals IPO | Medistep Healthcare IPO | |
|---|---|---|
| QIB (times) | 196.77x | |
| NII (times) | 597.23x | 289.15x |
| Big NII (times) | 670.18x | |
| Small NII (times) | 451.35x | |
| RII (times) | 401.36x | 461.11x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 270.19x | 375.20x |
